RESP

The economics of precision health: preventing air pollution-induced exacerbation in asthma

The demonstrable value of precision medicine, in the context of common environmental exposures, has scarcely been explored. This study evaluated the cost effectiveness of a preventive personalised intervention to reduce the adverse effect of air pollution...

The demonstrable value of precision medicine, in the context of common environmental exposures, has scarcely been explored. This...

The cost-effectiveness of as-needed budesonide-formoterol versus low-dose inhaled corticosteroid maintenance therapy in patients with mild asthma in Canada

Allergy Asthma Clin Immunol. 2021 Oct 12;17(1):108. doi: 10.1186/s13223-021-00610-w. PMID: 34641954.

The cost-effectiveness of as-needed budesonide/formoterol versus low-dose inhaled corticosteroid maintenance therapy in patients with mild asthma in the UK

Respiratory Medicine, 2020 (171); 106079

Cost-effectiveness of Implementing Objective Diagnostic Verification of Asthma in the United States

J Allergy Clin Immunol. 2019;S0091-6749(19)31634-3

Stability of asthma symptom control in a longitudinal study of mild–moderate asthmatics

J Allergy Clin Immunol Pract. 2017 Nov - Dec;5(6):1663-1670.e5

Complementary and alternative asthma treatments and their association with asthma control: a population-based study

BMJ Open. 2013 Sep 4;3(9):e003360

History of Asthma in Patients with Chronic Obstructive Pulmonary Disease: A Comparative Study of Economic Burden.

Ann Am Thorac Soc. 2016 Feb;13(2):188-96

The preventable burden of productivity loss due to suboptimal asthma control: a population-based study

Chest. 2014 Apr;145(4):787-793

The impact of comorbidities on productivity loss in asthma patients

Respir Res. 2016 Aug 26;17(1):106

Long-term effects of inhaled corticosteroids on bone mineral density in older women with asthma or COPD: a registry-based cohort study

Arch Osteoporos. 2018 Oct 29;13(1):116

Asthma is not associated with the need for surgery in Crohn’s disease when controlling for smoking status: a population-based cohort study.

Clin Epidemiol. 2018 Jul 12;10:831-840

The projected economic and health burden of sub-optimal asthma control in Canada

Respir Med. 2018 May;138:7-12

The global economic burden of asthma and chronic obstructive pulmonary disease

Int J Tuberc Lung Dis. 2016 Jan;20(1):11-23

Has asthma medication use caught up with the evidence? A 12-year population-based study of trends

Chest. 2017 Mar;151(3):612-618

Predictors of inappropriate usage of reliever medications in asthma: a 12-year population-based study

BMC Pulm Med. 2018 Feb 12;18(1):33.

Dispensation of long-acting β agonists with or without inhaled corticosteroids, and risk of asthma-related hospitalisation: a population-based study

Thorax. 2014 Apr;69(4):328-34

Comparative outcomes of leukotriene receptor antagonists and long-acting β-agonists as add-on therapy in asthmatic patients: a population-based study

J Allergy Clin Immunol. 2013 Jul;132(1):63-9

Influences of Socioeconomic Status on Costs of Asthma Under Universal Health Coverage

Med Care. 2016 Aug;54(8):789-95

Excess medical costs in patients with asthma and the role of comorbidity

Eur Respir J. 2016 Dec;48(6):1584-1592

Economic and health effect of full adherence to controller therapy in adults with uncontrolled asthma: A simulation study

J Allergy Clin Immunol. 2014 Oct;134(4):908-915.e3

The natural history of severe asthma and influences of early risk factors: a population-based cohort study

Thorax. 2016 Mar;71(3):267-75

Cost-effectiveness of bronchial thermoplasty, omalizumab, and standard therapy for moderate-to-severe allergic asthma

PLoS One. 2016 Jan 11;11(1):e0146003

The impact of inappropriate use of short acting beta agonists in asthma

Respir Med. 2017 Oct;131:135-140

One-year outcomes of inhaled controller therapies added to systemic corticosteroids after asthma-related hospital discharge

Respir Med. 2015 Mar;109(3):320-8

Post-hospital syndrome in adults with asthma: a case-crossover study

Allergy Asthma Clin Immunol. 2013 Dec 23;9(1):49

Costs and health outcomes associated with primary versus secondary care after an asthma-related hospitalization, a population-based study

Chest. 2013 Aug;144(2):428-435

The projected economic and health burden of uncontrolled asthma in the United States

Am J Respir Crit Care Med. 2019 Nov 1;200(9):1102-111

The economic burden of multimorbidity in severe asthma patients: a 20-year population-based study

Thorax. 2019 Dec;74(12):1113-1119

Saving in medical costs by achieving guideline-based asthma symptom control: a population-based study

This study aimed at informing an evidence gap in the literature. We have used a prospectively recruited sample, longitudinal evaluation of costs and control, and updated definitions of asthma control (according to the Global Initiative for Asthma [GINA] 20...

This study aimed at informing an evidence gap in the literature. We have used a prospectively recruited sample, longitudinal eva...

The additional burden of comorbidity along with asthma control on health-related quality of life in asthma

Using a longitudinal random sample of adults with asthma, we explored the performance of both generic and asthma-specific HRQoL instruments to simultaneously distinguish between different levels of asthma control and changes in comorbidity status. Our prim...

Using a longitudinal random sample of adults with asthma, we explored the performance of both generic and asthma-specific HRQoL...

Faculty of Pharmaceutical Sciences & UBC Division of Respiratory Medicine Respiratory Evaluation Sciences Program

Faculty of Pharmaceutical Sciences & UBC Division of Respiratory Medicine
Respiratory Evaluation Sciences Program